A Case of Pediatric Nephrolithiasis Associated with Topiramate Treatment
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Topiramate is an antiepileptic drug widely used to treat various seizures, mood disorders and migraine based on its various pharmacological mechanisms. Even though nephrolithiasis is listed as one of its side effects, there have been no cases reporting nephrolithiasis caused by use of topiramate on Korean pediatric patients. Since the use of topiramate is increasing in many patients, the possibility of nephrolithiasis after the treatment needs to be considered. Here, we report our experience in correcting neprholithiasis by simply discontinuing topiramate without administering any additional treatments.
Abstract
Topiramate is an antiepileptic drug widely used to treat various seizures, mood disorders and migraine based on its various pharmacological mechanisms. Even though nephrolithiasis is listed as one of its side effects, there have been no cases reporting nephrolithiasis caused by use of topiramate on Korean pediatric patients. Since the use of topiramate is increasing in many patients, the possibility of nephrolithiasis after the treatment needs to be considered. Here, we report our experience in correcting neprholithiasis by simply discontinuing topiramate without administering any additional treatments.
참고문헌 (14)
- Faught E, "Topiramate in Epilepsy: a comprehensive textbook. 2nd ed", pp.1663~1671 (2008), LWW
- Shank RP, "An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action", Epilepsia, 41, pp.S3~S9 (2000)
- Vega D, "Increased propensity for calcium phosphate kidney stones with topiramate use", Expert Opin Drug Saf, 6, pp.547~557 (2007)
- Elterman RD, "A double-blind, radomized tral of topiramate as adjunctive therapy for partial-onset seizures in children", Neurology, 52, pp.1338~1344 (1999)
- Biton V, "A radomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures", Neurology, 52, pp.1330~1337 (1999)
- McIntyre RS, "Open-label adjunctive topiramte in the treatment of unstable bipolar disorder", Can J Psychiatry, 50, pp.415~422 (2005)
- McElroy SL, "Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial", Am J Psychiatry, 160, pp.255~261 (2003)
- Winner P, "Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial", Headache, 45, pp.1304~1312 (2005)
- Gordon EE, "Effect of acetazolamide on citrate excretion and formation of renal calculi", N Engl J Med, 256, pp.1215~1219 (1957)
- Shorvon SD, "Safety of topiramate: adverse events and relationships to dosing", Epilepsia, 37, pp.S18~S22 (1996)
- Coppola G, "Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study", Epilepsy Res, 51, pp.147~153 (2002)
- Welch BJ, "Biochemical and stonerisk profiles with topiramate treatment", Am J Kidney Dis, 48, pp.555~563 (2006)
- Melnick JZ, "Adenosine triphosphate citrate lyase mediates hypocitraturia in rats", J Clin Invest, 98, pp.2381~2387 (1996)
- Preminger GM, "Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis", J Urol, 134, pp.20~23 (1985)